| Steris: May Benefit From Bringing Pharmaceutical Manufacturing Back To The U.S. |
Steris plc remains a Strong Buy with a fair value of $281, supported by robust organic growth and margin expansion. The Trump administration's push to reshore pharma manufacturing could be a major tailwind for Steris's AST business. Steris's balanced growth in pricing and volume, along with cost initiatives, positions it for continued operating margin improvement. |
seekingalpha.com |
2025-05-15 20:27:07 |
Czytaj oryginał (ang.) |
| STERIS plc (STE) Q4 2025 Earnings Call Transcript |
STERIS plc (NYSE:STE ) Q4 2025 Results Conference Call May 15, 2025 9:00 AM ET Company Participants Julie Winter - Investor Relations Mike Tokich - Senior Vice President and Chief Financial Officer Dan Carestio - President and Chief Executive Officer Conference Call Participants Dave Turkaly - Citizens Mike Matson - Needham & Company Patrick Wood - Morgan Stanley Mac Etoch - Stephens, Inc Michael Polark - Wolfe Research Jason Bednar - Piper Sandler Brett Fishbin - KeyBanc Operator Good morning, everyone, and welcome to the STERIS plc Fourth Quarter 2025 Conference Call. All participants will be in a listen-only mode. |
seekingalpha.com |
2025-05-15 17:52:08 |
Czytaj oryginał (ang.) |
| STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket |
STERIS' fourth-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues. |
zacks.com |
2025-05-15 13:41:04 |
Czytaj oryginał (ang.) |
| Here's What Key Metrics Tell Us About Steris (STE) Q4 Earnings |
Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-05-14 23:30:32 |
Czytaj oryginał (ang.) |
| Steris (STE) Surpasses Q4 Earnings Estimates |
Steris (STE) came out with quarterly earnings of $2.74 per share, beating the Zacks Consensus Estimate of $2.59 per share. This compares to earnings of $2.41 per share a year ago. |
zacks.com |
2025-05-14 22:45:24 |
Czytaj oryginał (ang.) |
| Steris forecasts annual profit above estimates on strong medical equipment sales |
Medical equipment maker Steris forecast annual profit above analysts' estimate on Wednesday, banking on strength in its biggest segment that sells sterilization products, sending its shares up more than 5% in extended trading. |
reuters.com |
2025-05-14 21:26:52 |
Czytaj oryginał (ang.) |
| Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers |
Medical equipment maker Steris (STE) on Wednesday afternoon reported fiscal fourth-quarter 2025 financial results. A summary of its key numbers is below. |
investopedia.com |
2025-05-14 21:06:05 |
Czytaj oryginał (ang.) |
| STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year |
DUBLIN, IRELAND, May 14, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 fourth quarter and full year ended March 31, 2025. Total revenue from continuing operations for the fourth quarter of fiscal 2025 increased 4% to $1.5 billion compared with $1.4 billion in the fourth quarter of fiscal 2024. Constant currency organic revenue growth from continuing operations for the fourth quarter was 6%. |
globenewswire.com |
2025-05-14 20:30:00 |
Czytaj oryginał (ang.) |
| What Analyst Projections for Key Metrics Reveal About Steris (STE) Q4 Earnings |
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. |
zacks.com |
2025-05-09 14:20:51 |
Czytaj oryginał (ang.) |
| STERIS Declares Dividend of $0.57 per share |
DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on June 26, 2025, to shareholders of record at the close of business on June 10, 2025. |
globenewswire.com |
2025-05-07 20:30:00 |
Czytaj oryginał (ang.) |
| 10 Undervalued Dividend Growth Stocks: May 2025 |
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and another comparing each stock's forward dividend yield with its 5-year average dividend yield. To rank stocks, I do a quality assessment and sort candidates by quality scores, breaking ties with additional metrics. |
seekingalpha.com |
2025-05-07 13:00:00 |
Czytaj oryginał (ang.) |
| Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates? |
STERIS is expected to have experienced an increase in bioprocessing demand in the fourth quarter. |
zacks.com |
2025-05-06 18:10:37 |
Czytaj oryginał (ang.) |
| STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025 |
DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and full year financial results at 9:00 a.m. ET on May 15, 2025. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. |
globenewswire.com |
2025-04-22 20:30:00 |
Czytaj oryginał (ang.) |
| Is it the Right Time to Hold STERIS Stock in Your Portfolio? |
STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment. |
zacks.com |
2025-04-16 15:25:40 |
Czytaj oryginał (ang.) |
| Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy' |
Upgraded Steris to 'strong buy' with a fair value of $254 per share due to strong recovery in its Applied Sterilization Technologies (AST) business. AST segment showed 9.5% organic growth, with management confident in further recovery despite challenges from rising labor costs and raw material inflation. For FY25, Steris guides for 6% revenue growth and 3.1% adjusted EPS growth, with significant contributions expected from Healthcare Products and AST segments. |
seekingalpha.com |
2025-03-22 09:22:30 |
Czytaj oryginał (ang.) |
| Steris (STE) Up 3% Since Last Earnings Report: Can It Continue? |
Steris (STE) reported earnings 30 days ago. What's next for the stock? |
zacks.com |
2025-03-07 14:36:21 |
Czytaj oryginał (ang.) |
| Steris (STE) International Revenue in Focus: Trends and Expectations |
Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects. |
zacks.com |
2025-02-10 12:21:43 |
Czytaj oryginał (ang.) |
| STERIS plc (STE) Q3 2025 Earnings Call Transcript |
STERIS plc (NYSE:STE ) Q3 2025 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Julie Winter – Investor Relations Mike Tokich – Senior Vice President and Chief Financial Officer Dan Carestio – President and Chief Executive Officer Conference Call Participants Jacob Johnson – Stephens Brett Fishbin – KeyBanc Michael Polark – Wolfe Research Jason Bednar – Piper Sandler Patrick Wood – Morgan Stanley Mike Matson – Needham & Company Dave Turkaly – Citizens Operator Good day, and welcome to the STERIS plc Third Quarter 2025 Conference Call. All participants will be in a listen-only mode. |
seekingalpha.com |
2025-02-06 16:52:37 |
Czytaj oryginał (ang.) |
| STE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket |
STERIS' third-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues. The lowered revenue guidance for fiscal 2025 is concerning. |
zacks.com |
2025-02-06 12:51:30 |
Czytaj oryginał (ang.) |
| Steris (STE) Reports Q3 Earnings: What Key Metrics Have to Say |
Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-02-05 21:36:16 |
Czytaj oryginał (ang.) |
| Steris (STE) Matches Q3 Earnings Estimates |
Steris (STE) came out with quarterly earnings of $2.32 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $2.22 per share a year ago. |
zacks.com |
2025-02-05 20:46:08 |
Czytaj oryginał (ang.) |
| Steris lowers annual profit forecast due to a stronger dollar |
Medical equipment maker Steris lowered its annual profit forecast on Wednesday, citing the impact of a stronger dollar. |
reuters.com |
2025-02-05 20:43:45 |
Czytaj oryginał (ang.) |
| STERIS Announces Financial Results for Fiscal 2025 Third Quarter |
DUBLIN, IRELAND, Feb. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 third quarter ended December 31, 2024. Total revenue from continuing operations for the third quarter of fiscal 2025 increased 6% to $1.4 billion compared with $1.3 billion in the third quarter of fiscal 2024. Constant currency organic revenue from continuing operations for the third quarter also increased 6%. |
globenewswire.com |
2025-02-05 18:30:00 |
Czytaj oryginał (ang.) |
| Can Steris (STE) Keep the Earnings Surprise Streak Alive? |
Steris (STE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
zacks.com |
2025-02-04 15:10:20 |
Czytaj oryginał (ang.) |
| Can These 5 MedTech Stocks Hit Earnings Targets This Season? |
Here is a sneak peek into how five MedTech stocks, BSX, HOLX, TECH, STE and ALGN, are expected to fare in their quarterly results, slated to be released tomorrow. |
zacks.com |
2025-02-04 14:10:43 |
Czytaj oryginał (ang.) |
| Wall Street's Insights Into Key Metrics Ahead of Steris (STE) Q3 Earnings |
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. |
zacks.com |
2025-02-04 12:20:41 |
Czytaj oryginał (ang.) |
| STE Gears Up for Q3 Earnings: Here's What You Need to Know |
STERIS' third-quarter fiscal 2025 results are likely to reflect the positives of normalizing the Healthcare backlog and increasing bioprocessing demand. |
zacks.com |
2025-01-31 12:21:12 |
Czytaj oryginał (ang.) |
| Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth |
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-01-30 13:06:41 |
Czytaj oryginał (ang.) |
| STERIS Declares Dividend of $0.57 per share |
DUBLIN, IRELAND, Jan. 28, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on March 21, 2025, to shareholders of record at the close of business on February 20, 2025. |
globenewswire.com |
2025-01-28 19:00:00 |
Czytaj oryginał (ang.) |
| Here's Why Steris (STE) is a Strong Momentum Stock |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-01-24 12:55:23 |
Czytaj oryginał (ang.) |
| Strategic Acquisitions to Support STERIS Stock Amid Macro Issues |
STE expects bioprocessing revenues to grow in the second half of fiscal 2025. |
zacks.com |
2025-01-23 13:21:09 |
Czytaj oryginał (ang.) |
| STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financial Results on February 6, 2025 |
DUBLIN, IRELAND , Jan. 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 third quarter financial results at 9:00 a.m. ET on February 6, 2025. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. |
globenewswire.com |
2025-01-22 18:30:00 |
Czytaj oryginał (ang.) |
| STERIS Announces Outcome of Ethylene Oxide Trial |
DUBLIN, IRELAND, Jan. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that a jury trial that had been ongoing since December 4, 2024, against Isomedix Operations, Inc. (“Isomedix”), a subsidiary of the Company, ended in a mistrial on January 17, 2025. |
globenewswire.com |
2025-01-21 08:30:00 |
Czytaj oryginał (ang.) |
| STERIS Gains From Expanded Product Offerings Amid Macro Issues |
STE expects bioprocessing revenues to grow in the second half of fiscal 2025. |
zacks.com |
2024-12-30 13:30:26 |
Czytaj oryginał (ang.) |
| Reasons to Retain STE Stock in Your Portfolio Now |
STERIS' strong prospects in the healthcare business bode well for investors. |
zacks.com |
2024-12-17 14:51:10 |
Czytaj oryginał (ang.) |
| Why Is Steris (STE) Up 0.9% Since Last Earnings Report? |
Steris (STE) reported earnings 30 days ago. What's next for the stock? |
zacks.com |
2024-12-09 08:48:35 |
Czytaj oryginał (ang.) |
| New Alliances to Support STERIS Stock Despite Macro Issues |
STE expects bioprocessing revenues to grow in the second half of fiscal 2025. |
zacks.com |
2024-11-27 12:40:46 |
Czytaj oryginał (ang.) |
| Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy' |
I am upgrading STERIS to a 'Buy' with a fair value of $240 per share due to the recent stock price pullback and solid growth prospects. STERIS reported 7.2% organic revenue growth and 5.4% adjusted EPS growth, with strong performance in the Applied Sterilization Technologies segment. Despite high interest rates, I anticipate a gradual recovery in the biotech industry, driving future double-digit revenue growth in STERIS' AST business. |
seekingalpha.com |
2024-11-17 22:58:32 |
Czytaj oryginał (ang.) |
| Why Steris (STE) International Revenue Trends Deserve Your Attention |
Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects. |
zacks.com |
2024-11-11 12:20:53 |
Czytaj oryginał (ang.) |
| STE Q2 Earnings Beat Estimates, Margins Dip, Stock Gains in Aftermarket |
STERIS' second-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues. The contraction of both margins is concerning. |
zacks.com |
2024-11-07 12:20:24 |
Czytaj oryginał (ang.) |
| Compared to Estimates, Steris (STE) Q2 Earnings: A Look at Key Metrics |
Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2024-11-06 22:01:29 |
Czytaj oryginał (ang.) |
| Steris (STE) Surpasses Q2 Earnings Estimates |
Steris (STE) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $2.11 per share. This compares to earnings of $2.03 per share a year ago. |
zacks.com |
2024-11-06 20:50:22 |
Czytaj oryginał (ang.) |
| Steris beats quarterly estimates on continued demand for medical procedures |
Medical equipment maker Steris beat second-quarter profit estimates on Wednesday, on continued demand for non-urgent medical procedures that boosted sales of its surgical and examination tools. |
reuters.com |
2024-11-06 19:44:33 |
Czytaj oryginał (ang.) |
| STERIS Announces Financial Results for Fiscal 2025 Second Quarter |
DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) -- - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. Total revenue from continuing operations for the second quarter of fiscal 2025 increased 7% to $1.3 billion compared with $1.2 billion in the second quarter of fiscal 2024. Constant currency organic revenue from continuing operations for the second quarter increased 7%. |
globenewswire.com |
2024-11-06 18:30:00 |
Czytaj oryginał (ang.) |
| Steris (STE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures |
Beyond analysts' top -and-bottom-line estimates for Steris (STE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024. |
zacks.com |
2024-11-01 12:20:29 |
Czytaj oryginał (ang.) |
| STERIS Declares Dividend of $0.57 per share |
DUBLIN, IRELAND, Oct. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on December 19, 2024, to shareholders of record at the close of business on November 19, 2024. |
globenewswire.com |
2024-10-30 18:30:00 |
Czytaj oryginał (ang.) |
| Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth |
Steris (STE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2024-10-30 13:07:02 |
Czytaj oryginał (ang.) |
| STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024 |
DUBLIN, IRELAND, Oct. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 second quarter financial results at 9:00 a.m. ET on November 7, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. |
globenewswire.com |
2024-10-23 20:30:00 |
Czytaj oryginał (ang.) |
| STE Gears Up for Q2 Earnings: Here's What You Need to Know |
STERIS' second-quarter fiscal 2025 results are likely to reflect the positives of normalizing the Healthcare backlog. |
zacks.com |
2024-10-21 14:10:26 |
Czytaj oryginał (ang.) |
| Steris (STE) Up 3% Since Last Earnings Report: Can It Continue? |
Steris (STE) reported earnings 30 days ago. What's next for the stock? |
zacks.com |
2024-09-05 16:35:53 |
Czytaj oryginał (ang.) |
| Reasons to Retain STERIS Stock in Your Portfolio for Now |
STE's strong prospects in the healthcare business arm bode well for investors. |
zacks.com |
2024-09-04 13:35:54 |
Czytaj oryginał (ang.) |
| 15 Upcoming Dividend Increases Including A King |
This week, 15 companies, including Dividend King Stanley Black & Decker, are set to increase dividends, with SWK extending its 57-year streak by 1.2%. My strategy focuses on buying, holding, and adding companies that consistently increase dividends and outperform benchmarks, using SCHD as a performance gauge. The list of dividend increases is curated by merging data from the "U.S. Dividend Champions" spreadsheet and NASDAQ, emphasizing companies with at least five years of dividend growth. |
seekingalpha.com |
2024-08-29 20:51:26 |
Czytaj oryginał (ang.) |
| STERIS to Present at the Morgan Stanley Healthcare Conference |
DUBLIN, IRELAND, Aug. 26, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 4, 2024. Dan Carestio, President and CEO of STERIS will present at 1:50 p.m. Eastern Time. |
globenewswire.com |
2024-08-26 20:30:00 |
Czytaj oryginał (ang.) |